• 1:国家卫生计生委合理用药专家委员会
• 2:中国药师协会

摘要(Abstract)：

<正>1前言ST段抬高型心肌梗死(ST-segment elevation myocardial infarction,STEMI)发病率、致残率、致死率均较高,及时有效的救治不仅能挽救患者的生命,而且能维持患者较高的生活和工作质量。STEMI的病理生理过程决定其治疗具有时间的迫切性和相关性,是机会性极强、时间有决定性意义的抢救性治疗。应特别强调,STEMI早期治疗才能挽救大片心肌,所以如何缩短心肌总缺血时间、尽早

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author):

参考文献(References)：

• [1]刘群,赵冬,刘军,代表中国冠心病二级预防架桥工程研究协作组.中国ST段抬高急性冠状动脉综合征诊疗现况调查[J].中华心血管病杂志,2009,37(3):213-217.
• [2]杨艳敏,朱俊,谭慧琼,等.中国ST段抬高的急性心肌梗死临床特征及治疗现状[J].中华医学杂志,2005,85(31):2176-2181.
• [3]杨进刚,皮林,宋莉,等.北京市急性ST段抬高型心肌梗死患者的院内预后和3年随访结果[J].中华心血管病杂志,2013,41(6):474-479.
• [4]张优,高传玉,段广才,等.河南省不同级别医院急性ST段抬高型心肌梗死患者早期再灌注治疗现状调查[J].中华心血管病杂志,2015,43(10):858-862.
• [5]Zhang Y,Yang S,Liu X,et al.Management of ST-segment elevation myocardial infarction in predominantly rural central China:A retrospective observational study[J].Medicine(Baltimore),2016,95(49):e5584.
• [6]国家卫生计生委合理用药专家委员会,中国药师协会.急性ST段抬高型心肌梗死溶栓治疗的合理用药指南[J].中国医学前沿杂志(电子版),2016,8(8):25-41.
• [7]Li J,Li X,Wang Q,et al.ST-segment elevation myocardial infarction in China from 2001 to 2011(the China PEACE-Retrosp ective Acute Myocardial Infarction Study):a retrosp ective analysis of hospital data[J].Lancet,2015,385(9966):441-451.
• [8]陈伟伟,高润霖,刘力生,等.《中国心血管病报告2017》概要[J].中国循环杂志,2018,33(1):1-8.
• [9]Ibanez B,James S,Agewall S,et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)[J].Eur Heart J,2018,39(2):119-177.
• [10]颜红兵,向定成,刘红梅,等.ST段抬高型急性心肌梗死院前溶栓治疗中国专家共识[J].中国医学前沿杂志(电子版),2018,10(4):1-10.
• [11]Bonow RO,Mann DL,Zipes DP,et al.Braunwald's Heart Disease:A Textbook of Cardiovascular Medicine[M].9th edition.Philadelphia:Elsevier Science,2011.
• [12]Hu S,Yonetsu T,Jia H,et al.Residual thrombus pattern in patients with ST-segment elevation myocardial infarction caused by plaque erosion versus plaque rupture after successful fibrinolysis:an optical coherence tomography study[J].J Am Coll Cardiol,2014,63(13):1336-1338.
• [13]Thygesen K,Alpert JS,Jaffe AS,et al.[Fourth universal definition of myocardial infarction(2018)][J].Kardiol Pol,2018,76(10):1383-1415.
• [14]Denktas AE,Anderson HV,McCarthy J,et al.Total ischemic time:the correct focus of attention for optimal ST-segment elevation myocardial infarction care[J].JACC Cardiovasc Interv,2011,4(6):599-604.
• [15]Jennings RB,Reimer KA.Factors involved in salvaging ischemic myocardium:effect of reperfusion of arterial blood[J].Circulation,1983,68(2 Pt 2):I25-I36.
• [16]Blancas R,López-Matamala B,Martínez-González O,et al.Primary angioplasty versus fibrinolysis in ST-segment elevation acute myocardial infarction:reassessing the best strategy[J].Med Intensiva,2013,37(7):499.
• [17]Harper RW.Pre-hospital thrombolysis rather than primary percutaneous intervention is the treatment of choice for patients with ST-segment elevation myocardial infarction presenting early after the onset of symptoms[J].JACC Cardiovasc Interv,2010,3(10):1093-1094.
• [18]Kozera G,Chwojnicki K,Gójska-Grymaj?o A,et al.Prehospital delays and intravenous thrombolysis in urban and rural areas[J].Acta Neurol Scand,2012,126(3):171-177.
• [19]Vora AN,Holmes DN,Rokos I,et al.Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care:a report from the USNational Cardiovascular Data Registry[J].JAMA Intern Med,2015,175(2):207-215.
• [20]Armstrong PW,Gershlick AH,Goldstein P,et al.Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction[J].N Engl J Med,2013,368(15):1379-1387.
• [21]Bakal JA,Westerhout CM,Cantor WJ,et al.Evaluation of early percutaneous coronary intervention vs.standard therapy after fibrinolysis for ST-segment elevation myocardial infarction:contribution of weighting the composite endpoint[J].Eur Heart J,2013,34(12):903-908.
• [22]Pu J,Ding S,Ge H,et al.Efficacy and Safety of a PharmacoInvasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction:EARLY-MYO Trial(Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction)[J].Circulation,2017,136(16):1462-1473.
• [23]Liu J,Fu XH,Xue L,et al.Equilibrium radionuclide angiog raphy for evaluating the effect of facilitated percutaneous coro nary intervention on ventricular synchrony in patients with acute myocardial infarction[J].Circ J,2012,76(4):928-935.
• [24]万方,张拓,沈玲红,等.急性ST段抬高心肌梗死溶栓后早期介入治疗与直接介入治疗的对比研究[J].中国介入心脏病学杂志,2013,21(1):3-7.
• [25]Borgia F,Goodman SG,Halvorsen S,et al.Early routine percutaneous coronary intervention after fibrinolysis vs.stand ard therapy in ST-segment elevation myocardial infarction:a metaanalysis[J].Eur Heart J,2010,31(17):2156-2169.
• [26]Geng W,Tian X,Fu X,et al.Early routine angioplasty versus selective angioplasty after successful thrombolysis in acute ST-segment elevation myocardial infarction[J].Coron Artery Dis,2013,24(3):238-243.
• [27]Tan NS,Goodman SG,Cantor WJ,et al.Comparison of the efficacy of pharmacoinvasive management for ST-segment elevation myocardial infarction in smokers versus non-smokers(from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction)[J].Am J Cardiol,2014,114(7):955-961.
• [28]Han YL,Liu JN,Jing QM,et al.The efficacy and safety of pharmacoinvasive therapy with prourokinase for acute ST-segment elevation myocardial infarction patients with expected long percutaneous coronary intervention-related delay[J].Cardiovasc Ther,2013,31(5):285-290.
• [29]Thiele H,Eitel I,Meinberg C,et al.Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset:the LIPSIA-STEMI trial(Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction)[J].JACC Cardiovasc Interv,2011,4(6):605-614.
• [30]龚志华,向定成,董凤英,等.区域协同救治体系对未具备经皮冠状动脉介入治疗能力医院救治急性ST段抬高心肌梗死患者的时间节点的影响[J].中国介入心脏病学杂志,2015,23(3):125-128.
• [31]宋莉,颜红兵,杨进刚,等.北京市急性ST段抬高心肌梗死患者转诊现况调查[J].中华心血管病杂志,2010,38(5):406-410.
• [32]段天兵,向定成,秦伟毅,等.建立区域协同救治网络对首诊于非冠状动脉介入治疗医院的急性心肌梗死患者再灌注时间及近期预后的影响[J].中华心血管病杂志,2014,42(8):641-645.
• [33]王斌,王焱,叶涛,等.区域协同ST段抬高型心肌梗死救治网络建设探讨[J].中华心血管病杂志,2014,42(8):650-654.
• [34]梁仪,徐良洁,严金川,等.新型区域协同救治模式对急性ST段抬高型心肌梗死治疗的影响[J].中华心血管病杂志,2014,42(8):646-649.
• [35]Le May MR,So DY,Dionne R,et al.A citywide protocol for primary PCI in ST-segment elevation myocardial infarction[J].N Engl J Med,2008,358(3):231-240.
• [36]Huber K,Gersh BJ,Goldstein P,et al.The organization,function,and outcomes of ST-elevation myocardial infarction networks worldwide:current state,unmet needs and future directions[J].Eur Heart J,2014,35(23):1526-1532.
• [37]Magid DJ,Wang Y,Herrin J,et al.Relationship between time of day,day of week,timeliness of reperfusion,and inhospital mortality for patients with acute ST-segment elevation myocardial infarction[J].JAMA,2005,294(7):803-812.
• [38]Holmes DR,Bell MR,Gersh BJ,et al.Systems of care to improve timeliness of reperfusion therapy for ST-segment elevation myocardial infarction during off hours:the Mayo Clinic STEMI protocol[J].JACC Cardiovasc Interv,2008,1(1):88-96.
• [39]Hutchings CB,Mann NC,Daya M,et al.Patients with chest pain calling 9-1-1 or self-transporting to reach definitive care:which mode is quicker[J].Am Heart J,2004,147(1):35-41.
• [40]Tubaro M,Danchin N,Goldstein P,et al.Pre-hospital treatment of STEMI patients.A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology[J].Acute Card Care,2011,13(2):56-67.
• [41]Windecker S,Kolh P,Alfonso F,et al.2014 ESC/EACTSGuidelines on myocardial revascularization:The Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC)and the European Association for CardioThoracic Surgery(EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI)[J].Eur Heart J,2014,35(37):2541-2619.
• [42]Morrow DA,Antman EM,Parsons L,et al.Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3[J].JAMA,2001,286(11):1356-1359.
• [43]Roberts R,Rogers WJ,Mueller HS,et al.Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction.Results of the Thrombolysis in Myocardial Infarction(TIMI)Ⅱ-B Study[J].Circulation,1991,83(2):422-437.
• [44]Chatterjee S,Chaudhuri D,Vedanthan R,et al.Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials[J].Int J Cardiol,2013,168(2):915-921.
• [45]Van de Werf F,Janssens L,Brzostek T,et al.Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy[J].J Am Coll Cardiol,1993,22(2):407-416.
• [46]Pizarro G,Fernández-Friera L,Fuster V,et al.Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction:results from the METOCARD-CNIC trial(Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction)[J].J Am Coll Cardiol,2014,63(22):2356-2362.
• [47]Park KL,Goldberg RJ,Anderson FA,et al.Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era(GRACE)[J].Am J Med,2014,127(6):503-511.
• [48]王文,谢晋湘,蒋立新,等.静脉及口服美托洛尔对急性心肌梗死住院患者血压与心率的影响(中国心脏研究-Ⅱβ阻滞剂预试验报告)[J].高血压杂志,2006,14(4):269-273.
• [49]Chen ZM,Pan HC,Chen YP,et al.Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction:randomised placebo-controlled trial[J].Lancet,2005,366(9497):1622-1632.
• [50]Su J,Fu X,Tian Y,et al.Additional predictive value of serum potassium to Thrombolysis In Myocardial Infarction risk score for early malignant ventricular arrhythmias in patients with acute myocardial infarction[J].Am J Emerg Med,2012,30(7):1089-1094.
• [51]傅向华,齐鹏,汪雁博,等.急性心肌梗死早期低钾血症与恶性室性心律失常的关系[C].第十三次全国心血管病学术会议论文集,2011.
• [52]Macdonald JE,Struthers AD.What is the optimal serum potassium level in cardiovascular patients[J].J Am Coll Cardiol,2004,43(2):155-161.
• [53]傅向华.低血钾相关性恶性室性心律失常[M]//胡大一,马长生.心脏病学实践2009--新进展与临床案例.北京:人民卫生出版社,2009:212-222.
• [54]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2015,43(5):380-393.
• [55]American College of Emergency Physicians,Society for Cardiovascular Angiography and Interventions,O'Gara PT,et al.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol,2013,61(4):e78-e140.
• [56]Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology(ESC),Steg PG,James SK,et al.ESC Guidelines for the management of acute myocardial infarction in patients presen ting with ST-segment elevation[J].Eur Heart J,2012,33(20):2569-2619.
• [57]Chung WY,Han MJ,Cho YS,et al.Effects of the early administration of heparin in patients with ST-elevation myoc ardial infarction treated by primary angioplasty[J].Circ J,2007,71(6):862-867.
• [58]Verheugt FW,Liem A,Zijlstra F,et al.High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction:results of the Heparin in Early Patency(HEAP)pilot study[J].J Am Coll Cardiol,1998,31(2):289-293.
• [59]陈金良,傅向华,马宁,等.溶栓前肝素治疗对急性心肌梗死后左室重构的影响[J].中国危重病急救医学,2001,13(3):164-166.
• [60]陈金良,傅向华,马宁,等.溶栓前肝素治疗对急性心肌梗死冠状动脉再通和梗死范围的影响[J].中国综合临床,2002,18(1):31-32.
• [61]郝伟,徐志香,郭素坤,等.肝素的使用时机对急性心肌梗死再灌注的影响[J].中西医结合心脑血管病杂志,2007,5(10):1001-1002.
• [62]Krumholz HM,Hennen J,Ridker PM,et al.Use and effectiveness of intravenous heparin therapy for treatment of acute myocardial infarction in the elderly[J].J Am Coll Cardiol,1998,31(5):973-979.
• [63]Gilchrist IC,Berkowitz SD,Thompson TD,et al.Heparin dosing and outcome in acute coronary syndromes:the GUSTO-Ⅱb experience.Global Use of Strategies to Open Occluded Coronary Arteries[J].Am Heart J,2002,144(1):73-80.
• [64]Collins R,Flather M,Peto R.GISSI-2:10%reduction in mortality with heparin in acute myocardial infarction[J].Lancet,1990,336(8712):439-440.
• [65]Giralt T,Carrillo X,Rodriguez-Leor O,et al.Time-dependent effects of unfractionated heparin in patients with ST-elevation myocardial infarction transferred for primary angioplasty[J].Int J Cardiol,2015,198:70-74.
• [66]Kang HJ,Clare RM,Gao R,et al.Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome:A retrospective analysis from the Platelet Inhibition and Patient Outcomes(PLATO)Trial[J].Am Heart J,2015,169(6):899-905.
• [67]Hermanides RS,Ottervanger JP,ten BJM,et al.Net clinical benefit of prehospital glycoproteinⅡb/Ⅲa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding:effect of tirofiban in patients at high risk of bleeding using CRUSADEbleeding score[J].J Invasive Cardiol,2012,24(3):84-89.
• [68]Ohman EM,Van de Werf F,Antman EM,et al.Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction:results of a randomized trial[J].Am Heart J,2005,150(1):79-88.
• [69]Martínez-Ríos MA,Rosas M,González H,et al.Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction[J].Am J Cardiol,2004,93(3):280-287.
• [70]McCaul M,Lourens A,Kredo T.Pre-hospital versus in-hospital thrombolysis for ST-elevation myocardial infarction[J].Cochrane Database Syst Rev,2014,(9):CD010191.
• [71]Geng W,Zhang Q,Liu J,et al.A randomized study of prourokinase during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction[J].J Interv Cardiol,2018,31(2):136-143.
• [72]Steg PG,Bonnefoy E,Chabaud S,et al.Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty:data from the CAPTIM randomized clinical trial[J].Circulation,2003,108(23):2851-2856.
• [73]Ross AM,Gao R,Coyne KS,et al.A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase:the TUCC trial[J].Am Heart J,2001,142(2):244-247.
• [74]Yusuf S,Mehta SR,Chrolavicius S,et al.Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction:the OASIS-6 randomized trial[J].JAMA,2006,295(13):1519-1530.
• [75]赵昕,韩雅玲,王效增,等.磺达肝癸钠对急性心肌梗死阿替普酶溶栓的疗效及安全性研究[J].中国实用内科杂志,2013,33(10):812-815,818.
• [76]Neuhaus KL,von ER,Tebbe U,et al.Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase:results of the rt-PA-APSAC patency study(TAPS)[J].J Am Coll Cardiol,1992,19(5):885-891.
• [77]Bode C,Smalling RW,Berg G,et al.Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase(recombinant plasminogen activator)and frontloaded,accelerated alteplase(recombinant tissue plasminogen activator)in patients with acute myocardial infarction.The RAPIDⅡInvestigators[J].Circulation,1996,94(5):891-898.
• [78]急性心肌梗死再灌注治疗研究协作组.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696.
• [79][No author listed].Randomised double-blind trial of recombinant pro-urokinase against streptokinase in acute myocardial infarction.PRIMI Trial Study Group[J].Lancet,1989,1(8643):863-868.
• [80]Zhao L,Zhao Z,Chen X,et al.Safety and efficacy of prourokinase injection in patients with ST-elevation myocardial infa rction:phaseⅣclinical trials of the prourokinase phase study[J].Heart Vessels,2018,33(5):507-512.
• [81]汪雁博,谷新顺,傅向华.国产重组人尿激酶原治疗急性心肌梗死有效性和安全性的Meta分析[J].中国全科医学,2016,19(17):2083-2088.
• [82]尿激酶原临床试验协作组,李天德,肖成祖,等.重组人尿激酶原治疗急性ST段抬高性心肌梗死的多中心Ⅲ期临床试验[J].医学研究杂志,2013,42(10):26-31.
• [83]B?r FW,Meyer J,Vermeer F,et al.Comparison of saruplase and alteplase in acute myocardial infarction.SESAM Study Group.The Study in Europe with Saruplase and Alteplase in Myocardial Infarction[J].Am J Cardiol,1997,79(6):727-732.
• [84]刘馨允,张优,李牧蔚,等.瑞替普酶治疗急性ST段抬高型心肌梗死多中心临床试验分析[J].中华心血管病杂志,2016,44(9):766-770.
• [85]刘馨允,张优,张华,等.瑞替普酶与尿激酶对急性心肌梗死患者院内治疗有效性及安全性的多中心随机对照研究[J].中国动脉硬化杂志,2016,24(11):1138-1142.
• [86]Global Use of Strategies to Open Occluded Coronary Arteries(GUSTOⅢ)Investigators.A comparison of reteplase with alteplase for acute myocardial infarction[J].N Engl J Med,1997,337(16):1118-1123.
• [87]GUSTO investigators.An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction[J].N Engl J Med,1993,329(10):673-682.
• [88]Assessment of the Safety and Efficacy of a New Thrombolytic(ASSENT-2)Investigators,Van De Werf F,Adgey J,et al.Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction:the ASSENT-2 double-blind randomised trial[J].Lancet,1999,354(9180):716-722.
• [89]Wilcox RG,der Lippe G,Olsson CG,et al.Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction.Anglo-Scandinavian Study of Early Thrombolysis(ASSET)[J].Lancet,1988,2(8610):525-530.
• [90]Cannon CP,Gibson CM,McCabe CH,et al.TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction:results of the TIMI 10Btrial.Thrombolysis in Myocardial Infarction(TIMI)10BInvestigators[J].Circulation,1998,98(25):2805-2814.
• [91]WEST Steering Committee.A comparison of pharmacologic therapy with/without timely coronary intervention vs.primary percutaneous intervention early after ST-elevation myocardial infarction:the WEST(Which Early ST-elevation myocardial infarction Therapy)study[J].Eur Heart J,2006,27(13):1530-1538.
• [92]翟玫,陈纪林,乔树宾,等.注射用重组人TNK组织型纤溶酶原激活剂溶栓治疗急性ST段抬高型心肌梗死的疗效和安全性评价[J].中国新药杂志,2016,25(1):82-86,92.
• [93]Mehran R,Pocock SJ,Nikolsky E,et al.A risk score to predict bleeding in patients with acute coronary syndromes[J].J Am Coll Cardiol,2010,55(23):2556-2566.
• [94]Bassand JP,Afzal R,Eikelboom J,et al.Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes[J].Eur Heart J,2010,31(1):50-58.
• [95]Mayer SA,Brun NC,Begtrup K,et al.Efficacy and safety of recombinant activated factorⅦfor acute intracerebral hemo rrhage[J].N Engl J Med,2008,358(20):2127-2137.
• [96]Schulman S,Beyth RJ,Kearon C,et al.Hemorrhagic complications of anticoagulant and thrombolytic treatment:American College of Chest Physicians Evidence-Based Clinical Practice Guid elines(8th Edition)[J].Chest,2008,133(6 Suppl):257S-298S.
• [97]Piccini JP,Berger JS,Brown DL.Early sustained ventricular arrhythmias complicating acute myocardial infarction[J].Am JMed,2008,121(9):797-804.
• [98]中华医学会心血管病学分会,中国生物医学工程学会心律分会,中国医师协会循证医学专业委员会,等.心律失常紧急处理专家共识[J].中华心血管病杂志,2013,41(5):363-376.
• [99]李勇,吕树铮,马临安,等.ST段抬高型心肌梗死患者血钾水平与原发性恶性室性心律失常的相关研究[J].现代生物医学进展,2010,10(13):2469-2472.
• [100]Hjalmarson A.Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period[J].Am J Cardiol,1997,80(9B):35J-39J.
• [101]郭继鸿.获得性长QT间期综合征的防治建议解读[J].中华心血管病杂志,2011,39(4):289-292.
• [102]Zipes DP,Camm AJ,Borggrefe M,et al.ACC/AHA/ESC2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary:A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society[J].Eur Heart J,2006,27(17):2099-2140.
• [103]Israel CW,Manegold JC.[Electrical storm:definition,prevalence,causes and prognostic implications][J].Herzschr ittmacherther Elektrophysiol,2014,25(2):59-65.
• [104]Sorajja D,Munger TM,Shen WK.Optimal antiarrhythmic drug therapy for electrical storm[J].J Biomed Res,2015,29(1):20-34.
• [105]郭继鸿.β受体阻滞剂在心律失常治疗中的应用[J].中国心脏起搏与心电生理杂志,2007,21(1):4-6.
• [106]Meine TJ,Al-Khatib SM,Alexander JH,et al.Incidence,predictors,and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with th